Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma
Karisa C. Schreck(Johns Hopkins University), Roy E. Strowd(Wake Forest University), Fang‐Chi Hsu(Wake Forest University), Peter B. Barker(Johns Hopkins University), Linda Easter(University of Nottingham), Eric H. Kossoff(Johns Hopkins University), Diane Vizthum(University of Nottingham), Jaishri O. Blakeley(Johns Hopkins University), Bobbie J. Henry-Barron(Johns Hopkins University), Adam Berrington(University of Nottingham), Christopher T. Whitlow(University of Nottingham), Mackenzie C. Cervenka(University of Nottingham), Lindsay Blair(University of Nottingham)
Cited by 66
Related Papers
Novel genetic associations for blood pressure identified via gene-alcohol interaction in up to 570K individuals across multiple ancestries
|PLoS ONE|2018|1.2k
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
|Genetics in Medicine|2021|766
Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group
|Epilepsia|2008|603
A Modified Atkins Diet Is Effective for the Treatment of Intractable Pediatric Epilepsy
|Epilepsia|2006|370
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder
|Translational Psychiatry|2021|341